652 employees
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company.
2000
$100M
from 2 investors over 2 rounds
HUTCHMED raised $100M on June 25, 2020
Investors: General Atlantic
HUTCHMED raised $7.7M on December 21, 2010
Investors: SoftBank China Capital